Pre-market · Oct 6, 4:10 am ET · After hours $95.69 +1.20%
Open$97.56
Prev close$96.99
Day range$94.18 – $98.51
Volume207.1K
Market cap$1.39B
P/E (TTM)–
Dividend yield–
INBX Stock News
Headlines matching Inhibrx Biosciences or the INBX ticker, most recent first.
Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), Inhibrx Biosciences Inc (INBX) and Circle Internet Group, Inc. Class A (CRCL)TipRanks · 9 Sep 2026
LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $230Market news · 8 Sep 2026
H.C. Wainwright Initiates Inhibrx Biosciences(INBX.US) With Buy Rating, Announces Target Price $245Market news · 25 Aug 2026
Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $325Market news · 21 Aug 2026
Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $325Market news · 15 May 2026
LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $230Market news · 11 May 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Fractyl Health, Inc. (GUTS) and Inhibrx Biosciences Inc (INBX)TipRanks · 11 May 2026
LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $200Market news · 26 Apr 2026
LifeSci Capital Initiates Inhibrx Biosciences(INBX.US) With Buy Rating, Announces Target Price $200Market news · 24 Apr 2026
Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $300Market news · 22 Apr 2026
No comments yet — be the first to weigh in on INBX.